Prescient is an evidence-based decision-support partner to the pharmaceutical and biotech industries whose mission is to optimally shape new product, brand and mature product planning strategies.

Our diverse yet integrated skillsets and methodologies ensure our clients’ key decisions are objectively assessed from both a clinical and commercial perspective, resulting in differentiated products and offerings.


Shaping Decisions Driving Value

Our People

Prescient’s team consists of highly experienced executives who share our core values of thinking collaboratively, creatively and constructively. We effectively integrate different skills and perspectives into a single client-engagement team.

Our Approach

The format and scope of our engagements are customized to meet our clients’ needs and our ‘best-in-front’ team philosophy ensures access to the necessary levels of expertise and thinking.

Our Clients

We engage directly with a number of functions supporting new product, brand and mature product planning activities; to view a full list of these, please click the
link below.

Latest News

Aspirin targets key protein in neurodegenerative diseases

Synapse discovery could lead to new treatments for Alzheimer's disease

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatra …

Researchers discover how immune cells resist radiation treatment

Roche receives EU approval of Cotellic for use in combination with Zelboraf in advanced melanoma

FDA approves Opdivo to treat advanced form of kidney cancer

New finding offers hope for diabetic wound healing

AstraZeneca enters into agreement with Perrigo for rights to Entocort® in the US

New research suggests a novel route in the fight against cancer

Bayer's new five-year-contraceptive submitted for EU and US marketing authorization

Diabetes drug could be used to combat fatty liver disease

Study finds that Ebola vaccine is safe and stimulates strong immune response

Merck and Pfizer receive FDA Breakthrough Therapy designation for avelumab in metastatic Merkel cell …

Roche to restructure its manufacturing network for small molecules

Global partners announce donation of 500 millionth dose of azithromycin

Pfizer turns to GPCR experts at Heptares for a lineup of new drugs

UPDATED: Star fund manager Woodford calls in ex-FBI agent to probe Northwest Bio allegations

UPDATED: Roche abandons a marquee antibiotics collaboration with Polyphor

The most popular FierceBiotech stories of 2015

Novo Nordisk taps Ablynx in a $400M deal

Allergan scoops up some CNS drugs as its $160B Pfizer merger pends

Teva wagers up to $410M on Heptares' migraine program

BioMarin's hopes in DMD fade after FDA panel pillories its case for approval

Buzz: Shire is coming back for Baxalta with cash-plus-stock bid

Lilly's middling lung cancer drug wins FDA approval with a restrictive label

China and USA to further strengthen cooperation in drug supervision

Teva and Takeda to establish joint business for generics in Japan

Merck looks set to sell Allergopharma, according to sources

Ukrainian drugmakers may lose domestic pharma market share

Exclusive: Vyome Biosciences set for regulatory filing for new acne treatment by year-end

Eisai enters Chinese generics market with acquisition of drugmaker TianYi

Servier to axe 610 jobs

Hikma Pharmaceuticals to build plant in Kazakhstan

India moves to offer drugs at lower prices through Jan Aushadhi campaign

Almirall to grow dermatology portfolio with acquisition of Poli Group

Helsinn says EMA accepts marketing authorization application for anamorelin

ReproCELL buys UK firm Biopta, expanding drug discovery services

Ablynx names Robert Zeldin to CMO

GSK adopts reforms to revamp China business

When Botox met Viagra

Medical News Today: Yet another role for aspirin?

Medical News Today: Some sugar-free drinks can also damage teeth, experts warn

Medical News Today: Weight loss can preserve knee cartilage in obese people

Medical News Today: Could testosterone therapy benefit men with type 2 diabetes?

Medical News Today: Food prices influence how we judge food quality

Medical News Today: People who follow their instincts might be more trustworthy

Medical News Today: Women drink almost as much as men, study finds

Medical News Today: Children with pets have less stress

Medical News Today: How fatty foods could be damaging your brain

Medical News Today: Stress worsens skin woes for students

Medical News Today: Probiotics 'offer no health benefits' for preterm infants

Medical News Today: High-potency cannabis damages key brain structure

Medical News Today: Alzheimer's: newly identified molecular mechanism could lead to treatment

Medical News Today: Known enzymes could be treasure trove for drug discovery

Medical News Today: Study uncovers key step in malaria parasite's invasion of the liver

EU review for novel cancer-related weight-loss and muscle wasting drug

London's ambulance trust first to be placed in special measures

BMS' Opdivo hits stumbling block in quest for expansion

MP back 20% tax on sugary drinks to fight childhood obesity

Roche drops out of antibiotic development deal

Boehringer's Pradaxa antidote gets EU approval

Patient satisfaction with GP access on the decline, says NAO

Amgen files Humira biosimilar in the US

Long-acting haemophilia A drug approved for UK use

Novartis launches lung cancer drug, but fears limited access

More News